Company presentations – in media (video/audio)
| |
2024-03-19
Isofol Investor meeting March 19, 2024 (webcast) >> | |
2024-03-19
Isofol Investor meeting March 19, 2024 (pdf) >> | |
2023-05-03
Isofol audiocast – Interim Report Q1 2023 (sv) >> | |
2023-02-22
Isofol audiocast – Year-end report 2022 (Swedish) >> | |
2023-01-30
Isofol audiocast – Informational meeting for shareholders (Swedish) >> |
|
2022-11-11
Isofol audiocast – Interim Report Q3 2022 (eng) >> | |
2022-09-08
Redeye – CEO Interview (swedish) >> | |
2022-08-23
Isofol audiocast – Interim Report Q2 2022 (eng) >> | |
2022-08-04
Isofol audiocast – Top-line result in the AGENT study >> | |
2022-06-20
Live-streamed R&D Event >> | |
2022-05-18
AGBSC Life Summit (eng) >> | |
2022-05-12
Isofol audiocast – Interim Report Q1 2022 (eng) >> | |
2022-04-22
Isofol audiocast – AGENT study update (eng) >> | |
2022-01-24
Redeye Fight Cancer Seminar 2022 >> | |
2021-12-06
Isofol audiocast (eng) >> | |
2021-11-15
Redeye Life Science Day 2021, Investment case (eng) >> | |
2021-10-21
Interview with CEO Ulf Jungnelius, Pareto Securities, Sweden >> | |
2021-09-01
LSX Nordic Congress 2021 >> | |
2021-09-01
Pareto Securites´Healthcare Conference 2021, Sweden >> | |
2021-06-18
CEO speech ahead of the AGM 2021, Sweden >> | |
2021-06-09
Aktiespararna, Småbolagsdagarna 2021, Sweden >> | |
2021-06-08
Interview with CEO Ulf Jungnelius, Pareto Securities, Sweden >> | |
2021-06-07
RedEye, Growth Day 2021, Sweden >> | |
2021-03-31
RedEye, Interview with CEO, Ulf Jungnelius >> | |
2021-03-25
RedEye, Investor Forum, Sweden >> | |
2021-03-22
Isofol, press conference, Sweden >> | |
2021-01-21
RedEye, Fight Cancer 2021, Sweden >> | |
2020-12-15
DNB Nordic Healthcare Conference 2020, Sweden >> | |
2020-11-23
Stock market evening, Sweden >> | |
2020-11-02
Isofol – Press conference Licensing agreement with Endo/Paladin (pdf) >> | |
2020-09-03
Interview with CEO Ulf Jungnelius, Pareto, Sweden >> | |
2020-08-13
Interview with CEO Ulf Jungnelius, Dagens Industri, Sweden >> | |
2020-08-13
Isofol – Press conference Licensing agreement with Solasia (pdf) >> | |
2020-06-02
RedEye, Growth Day 2020, Sweden >> | |
2020-05-06
Interview with CEO Ulf Jungnelius, Sweden >> | |
2020-03-11
RedEye, Fight Cancer Seminar, Sweden >> | |
2020-05-06
Interview with CEO Ulf Jungnelius, Sweden >> | |
2020-03-11
RedEye, Fight Cancer Seminar, Sweden >> | |
2020-02-11
Empowered Patient Podcast, USA >> | |
2020-01-30
Isofol´s onocology seminar with
prof. Sebastian Stintzing as keynote speaker >> | |
2019-11-19
RedEye, Life Science Day, Sweden >> | |
2019-09-12
Pareto Securities´ Health Care Conference, Sweden >> | |
2019-06-06
Oncology Tube during ASCO, USA >> | |
2019-04-08
The Cancer Gene podcast, USA >> | |
2019-01-30
Empowered Patient Podcast, USA >> | |
2019-01-07
LifeSci PR CMO/CSO Roundtable discussion
during JP Morgan, USA >> | |
2017-11-13
The Nordic-American Life Science Conference, USA >> | |
